Mice deficient in TNF-a (TNF-a À/À mice) are resistant to skin carcinogenesis and expression of MMP-9 is inhibited in TNF-a À/À mice during skin tumour development. In the early stages of tumour promotion, MMP-9 protein initially localized to the follicular epidermis but subsequently began to accumulate in the interfollicular epidermis of wild-type but not TNF-a À/À mice. Inhibition of TNF-a or MMP-9 function reduced keratinocyte migration in vitro. In addition, a deficiency of TNF-a delayed re-epithelialization in vivo and this correlated with reduced MMP-9 expression. Collectively, these data suggest that MMP-9 regulates keratinocyte migration in a TNF-a-dependent manner. Expression profiling of genes that control cell adhesion and migration revealed markedly lower levels of the integrin subunits av and b6 in TNF-a À/À compared with wild-type keratinocytes in vitro. avb6 expression was upregulated by keratinocytes in vitro and during tumour promotion in vivo in a TNF-adependent manner. Furthermore, avb6 blockade significantly inhibited keratinocyte migration and TNFa-stimulated MMP-9 expression in vitro. These data illustrate a novel TNF-a-dependent mechanism for the control of avb6 expression and suggest one pathway for TNF-a regulation of MMP-9. Increased MMP-9 and avb6 expression may stimulate epithelial cell migration during tumour formation and may be one mechanism whereby TNF-a acts as an endogenous tumour promoter.
Introduction
Chemical carcinogenesis of the skin is a multistage process that involves initiation, promotion and progression. Initiation is rapid and irreversible and is thought to involve the conversion of some epidermal cells into latent neoplastic cells (Morris, 2000a) . Initiated epidermis is visibly unchanged and normal epidermal turnover continues (DiGiovanni et al., 1994; Yuspa, 1998) . The target cells for initiation in mouse epidermis are believed to be epidermal stem cells, which are thought to reside in both interfollicular and follicular epidermis (Morris et al., 2000b) . Promotion is a long-term process that requires repeated exposure to a tumour promotor and elicits expression of the neoplastic change by chronic regenerative hyperplasia (DiGiovanni et al., 1994; Morris et al., 2000b) . Selective clonal expansion of initiated cells into visible clonal outgrowths (papillomas) subsequently occurs. Clonal expansion of initiated follicular stem cells has been reported to involve migration out of the hair follicle and into the surrounding interfollicular epidermis (Binder et al., 1997) . Tumour progression in the skin carcinogenesis model involves the conversion of papillomas to squamous cell carcinomas (SCC) and is associated with additional genetic alterations (Frame et al., 1998) .
TNF-a is a key mediator of inflammation (Locksley et al., 2001) . Studies in our laboratory and by others have shown that TNF-a plays a major role in skin tumour development. Mice deficient in TNF-a (TNF-a À/À mice) or TNF-a receptor 1 (TNFR1 À/À mice) were resistant to tumour formation when subjected to chemical carcinogenesis of the skin (Moore et al., 1999; Suganuma et al., 1999; Arnott et al., 2004) . Tumour multiplicity in TNF-a À/À mice was reduced by 480% on all genetic backgrounds examined (Moore et al., 1999; Arnott et al., 2002; Scott et al., 2003) , and recent data suggest that TNF-a plays a role in tumour promotion rather than initiation (Arnott et al., 2002) .
Application of the tumour promotor 12-O-tetradecanoylphorbol-13-acetate (TPA) to mouse skin results in epidermal hyperplasia and TNF-a, which is induced exclusively in epidermis following TPA treatment (Moore et al., 1999; Scott et al., 2003) , is likely to play a role in this process. Investigation of TPA-mediated signalling events in epidermis has revealed differential activation kinetics of the transcription factor AP-1 in TNF-a À/À mice (Arnott et al., 2002) . Moreover, TPAinduced expression of a subset of AP-1 responsive genes was found to be reduced in TNF-a À/À compared with wt epidermis (Arnott et al., 2002) . One of these AP-1 responsive genes was matrix metalloproteinase-9 (MMP-9).
TNF-a is a major regulator of MMP-9 in a variety of cell types (Van den Steen et al., 2002) . MMP-9 is expressed by normal keratinocytes (Han et al., 2001; Kobayashi et al., 2001) and is induced in migrating keratinocytes following wounding in vitro (McCawley et al., 1998) and in vivo (Lund et al., 1999; Mohan et al., 2002) . Transformed keratinocytes and SCC also express MMP-9 (Papathoma et al., 2001; Thomas et al., 2001a) . MMP-9 has been extensively studied in many human and murine cancers due to its potential role in tumour invasion and metastasis (Naylor et al., 1994; Liabakk et al., 1996; Hanemaaijer et al., 2000; Scott et al., 2000) . In many types of established cancers, MMP-9 in the tumour microenvironment is provided by host inflammatory infiltrate (Naylor et al., 1994; Nielsen et al., 1996; Bergers et al., 2000; Coussens et al., 2000) . However, few studies concentrate on the role of MMP-9 during early stages of tumour formation.
In the present study we have used BALB/c wild-type (wt) and TNF-a À/À mice to further investigate the role of TNF-a in skin tumour development. Since keratinocyte migration is believed to be critical for clonal expansion, our hypothesis was that TPA-induced TNF-a may stimulate migration of keratinocytes from the hair follicle into the surrounding interfollicular epidermis and that MMP-9 may play a crucial role in this process. We present evidence here to show that TNF-a regulates epithelial MMP-9 expression during tumour promotion and TNF-a-stimulated keratinocyte migration occurs via an MMP-9-dependent pathway. In addition we describe a novel mechanism for the regulation of avb6 expression, an integrin known to promote a migratory phenotype in keratinocytes. We propose that decreased induction of MMP-9 and avb6 in TNF-a À/À epidermis may result in reduced keratinocyte migration during tumour promotion and may contribute to the tumour resistant phenotype of TNF-a À/À mice.
Results
MMP-9 mRNA expression is localized to follicular epithelial cells during the early stages of tumour promotion and is differentially regulated in TNF-a À/À mice MMP-9 mRNA was not detected in control skin but was induced during tumour promotion in wt and TNFa À/À mice when measured by in situ hybridization (ISH). MMP-9 expression was maximal at 24 h following one application of TPA and was exclusively localized to follicular epithelial cells (Figure 1a ; i-iv). Thus, induction of MMP-9 appeared to be a specific event, localized to a particular compartment of the epidermis. MMP-9 mRNA expression in hair follicles appeared to be markedly reduced in TNF-a À/À mice compared with wt ( Figure 1a ; ii and iv compared with i and iii, respectively). To quantify TPA-induced MMP-9 expression, epidermis from wt and TNF-a À/À mice was separated into interfollicular and follicular fractions and MMP-9 mRNA levels were measured by real time RT-PCR (Figure 1b) . MMP-9 expression was reduced in both TNF-a À/À interfollicular and follicular epidermis 8, 24 and 48 h after one application of TPA when compared with wt ( Figure 1b ; i and ii). Although MMP-9 expression was reduced in TNF-a À/À interfollicular epidermis (2.4-fold lower in TNF-a À/À compared with wt at 24 h), the major difference in MMP-9 levels was observed in follicular epidermis (19.5-fold lower in TNF-a À/À compared with wt at 24 h). These data correlated with the MMP-9 expression pattern observed by ISH (Figure 1a ).
MMP-9 mRNA expression extends to interfollicular epidermis as tumour promotion proceeds
In order to establish whether MMP-9 mRNA expression was exclusively localized to follicular epithelial cells for the duration of tumour promotion, we investigated the induction of MMP-9 mRNA by ISH after multiple applications of TPA (1-30 applications). The intensity of MMP-9 mRNA expression increased in wt skin as tumour promotion progressed (Figure 2 ). Although MMP-9 mRNA expression remained localized to follicular epithelial cells after 10 applications of TPA, MMP-9 mRNA was also induced in interfollicular keratinocytes that were in close proximity to hair follicles ( Figure 2a) . By 30 applications of TPA, follicular epithelial cells and a large proportion of interfollicular keratinocytes strongly expressed MMP-9 mRNA in wt epidermis (Figure 2b ). MMP-9 mRNA expression was reduced in TNF-a À/À compared with wt mice at most time points (data not shown). Importantly, MMP-9 mRNA expression was never observed in the dermis or inflammatory cells of the dermis even after 30 applications of TPA in either wt or TNF-a À/À mice.
MMP-9 protein accumulates in interfollicular epidermis during tumour promotion in a TNF-a-dependent manner
Since MMP-9 mRNA expression in wt mice initially localized to follicular epithelium but localization extended to interfollicular epidermis with repeated applications of TPA, we next examined whether MMP-9 protein expression followed a similar pattern in wt and TNF-a À/À mice. MMP-9 protein levels were measured in follicular and interfollicular epidermal fractions by zymography, a sensitive technique known to detect picograms of protein (Leber and Balkwill, 1997) . MMP-9 protein was not detected in control samples at any time point analysed (data not shown), but MMP-9 protein expression was observed in both interfollicular and follicular epidermis after TPA treatment (Figure 3 , top and middle panel). MMP-9 protein was barely detectable in the interfollicular epidermis of wt and TNF-a À/À mice after one application of TPA; almost all the MMP-9 protein was located in follicular epidermis (Figure 3) . Interestingly, the level of MMP-9 protein in wt and TNF-a À/À follicular epidermis was similar after one and four applications of TPA. These data are in contrast to the results obtained by ISH and real time RT-PCR (Figure 1) , where a clear reduction in MMP-9 mRNA was observed in TNF-a À/À compared with wt follicular epidermis. One explanation for this may be the release of stored MMP-9 protein from inflammatory infiltrate recruited to the dermis after TPA treatment. Although MMP-9 mRNA expression was exclusively localized to follicular epidermal cells after TPA treatment, immune cells are known to store MMP-9 protein in secretory granules (Van den Steen et al., 2002) , and this MMP-9 protein may be contained in the follicular epidermal fraction. As the number of TPA applications increased, MMP-9 protein levels began to increase in interfollicular epidermis with a corresponding decrease in follicular epidermis in wt mice (Figure 3 , top panel compared with middle panel). These data are in agreement with the MMP-9 expression pattern observed by ISH after repeated applications of TPA; In addition to MMP-9 mRNA being localized to hair follicles MMP-9 mRNA was also induced in wt interfollicular keratinocytes (Figure 2 ). In contrast, MMP-9 protein did not accumulate in TNF-a À/À interfollicular epidermis with repeated applications of TPA (Figure 3, top panel) . These data suggest that the presence of TNF-a is critical for accumulation of interfollicular MMP-9 protein during the early stages of tumour promotion.
Figure 1 MMP-9 mRNA expression is localized to follicular epithelial cells during the initial phase of tumour promotion and is differentially regulated in TNF-a À/À mice. wt and TNF-a À/À skin sections were analysed for MMP-9 mRNA expression by ISH (a). Expression was localized to hair follicles in both wt (i and iii) and TNF-a À/À mice (ii and iv) 24 h after one application of TPA ( Â 200 magnification). Arrows indicate areas of MMP-9 expression (i-iv) and interfollicular epidermis (IFE) and follicular epidermis (FE) are labelled in (i). MMP-9 mRNA expression was measured by real time RT-PCR in wt and TNF-a À/À epidermis at the times indicated after one application of TPA (b). Induction of MMP-9 mRNA by TPA in wt (') and TNF-a À/À (&) skin was compared directly at each time point in interfollicular epidermis (i) and follicular epidermis (ii). Error bars represent mean7s.e., (n ¼ 3). Data are representative of at least two independent experiments TIMP-3 protein expression is differentially regulated in TNF-a À/À interfollicular epidermis
In addition to transcriptional regulation, MMP activity is also controlled by specific inhibitors known as tissue inhibitors of matrix metalloproteinases (TIMPs; Van den Steen et al., 2002) . The levels of TIMP-1, TIMP-2 and TIMP-3 protein during tumour promotion were measured in skin homogenates by reverse zymography. TIMP-1 and TIMP-2 were not detected at any time point (data not shown) but TIMP-3 was induced by TPA and was detected exclusively in interfollicular epidermis ( Figure 3 , lower panel). TIMP-3 was first observed after 4 applications of TPA and levels persisted for the duration of the timecourse (1-10 applications).
The level of TIMP-3 was elevated in TNF-a À/À epidermis after five applications of TPA ( Figure 3 , lower panel). Hence, TIMP-3 expression increased in TNF-a À/À interfollicular epidermis at the point when MMP-9 began to accumulate in wt interfollicular epidermis.
Collectively, these data suggest that TNF-a regulates MMP-9 expression and localization in skin during tumour promotion. Keratinocyte migration from the hair follicle to the interfollicular epidermis is thought to be necessary for clonal expansion to occur during tumour promotion (Binder et al., 1997) , and MMP-9 is induced in migrating keratinocytes (McCawley et al., 1998; Lund et al., 1999; Mohan et al., 2002) . Thus, we thought it possible that TNF-a may regulate keratinocyte migration during tumour promotion and that MMP-9 may play a role in this process. It proved difficult to test this theory using the skin carcinogenesis model in vivo. Thus, we investigated the role of TNF-a during keratinocyte migration in vitro and re-epithelialization following wounding in vivo.
Blockade of TNF-a or MMP-9 function inhibits keratinocyte migration in vitro Keratinocytes were isolated from newborn mice and cultured on type I collagen in the presence of 0.01 mM calcium. The growth rates of keratinocytes isolated from wt and TNF-a À/À mice were similar over a period of 5 days (data not shown). wt and TNF-a À/À keratinocyte migration was measured using 8 mm pore inserts coated with matrigel. Significantly, more wt than TNF-a À/À keratinocytes migrated through matrigel coated inserts (Figure 4a , 6.8-fold; Po0.0001). Furthermore, treatment of wt keratinocytes with a TNF-a neutralizing antibody significantly retarded migration compared with control ( Figure 4a , Po0.0001). Keratinocyte migration was also measured in the presence of TIMP-3, a neutralizing antibody to MMP-9 or a synthetic MMP inhibitor. All three treatments significantly inhibited migration compared with control ( Figure 4b , Po0.0001). Keratinocyte viability was not affected by treatment with anti-TNF-a antibody, anti-MMP-9 antibody, TIMP-3 or synthetic MMP inhibitor (data not shown). Collectively, these data illustrate that both TNF-a and MMP-9 play an important role in migration of primary keratinocytes in vitro. TNF-a regulates the rate of re-epithelialization during wound healing in vivo
To determine the importance of TNF-a in keratinocyte migration in vivo, re-epithelialization during wound healing was analysed in wt and TNF-a À/À mice. Histological analysis of wt wounds revealed that keratinocytes from the wound edge had begun to migrate across the wound bed by day 1 postinjury. By day 2, a substantial area of the wound was covered with neoepidermis in wt mice (Figure 5a ) and re-epithelialization was complete by days 5-6 postinjury. However, wound re-epithelialization was retarded in TNF-a À/À compared with wt mice (Figure 5b compared with 5a respectively). The delay in re-epithelialization was transient since both wt and TNF-a À/À wounds were completely covered with a layer of neoepidermis 5-6 days following injury. Furthermore, keratinocyte proliferation in wt and TNF-a À/À wounds was not significantly different in sections analysed from days 1 to 14 postinjury as measured by BrdU-incorporation (data not shown). These data suggest that the delay in reepithelialization observed in TNF-a À/À mice was more likely due to inhibition of keratinocyte migration rather than decreased proliferation. Figure 4 Blockade of TNF-a or MMP-9 function inhibits keratinocyte migration in vitro. Migration of keratinocytes in vitro was measured using migration chambers coated with matrigel. Results are expressed as number of cells per field ( Â 200 magnification). Error bars represent mean7s.e., (n427). Where indicated the following additions were present in the upper chamber; 1 mg/ml of an anti-mouse TNF-a antibody, 5 ng/ml murine TIMP-3 protein, 1 mg/ml of an anti-mouse MMP-9 antibody and 15 nM of an MMP inhibitor. Blockade of TNF-a (a) or MMP-9 (b) function inhibits migration of keratinocytes (asterisk denotes Po0.0001). Data are representative of at least two independent experiments TNF-a protein is induced during the initial stages of wound healing and MMP-9 is differentially regulated in TNF-a À/À mice
Since an initial delay in wound healing was observed in TNF-a À/À mice, we examined TNF-a protein expression in wt wounds 0-10 days postinjury. The level of TNF-a, measured by ELISA, in nonwounded skin extracts was below the detection limits of the assay (5.1 pg TNF-a protein). TNF-a protein was induced following injury and the levels were maximal at 1 and 3 days following wounding (13 and 17 pg/mg total protein respectively). The level of TNF-a protein observed at 1 and 3 days postwounding was similar to TNF-a levels observed in wt epidermis during tumour promotion Arnott et al., 2004) . TNF-a expression during wounding healing was transient since TNF-a protein was not detectable at 6, 8 or 10 days postinjury.
To investigate the putative role of MMP-9 in wound healing and its possible regulation by TNF-a, MMP-9 protein levels in wt and TNF-a À/À wound homogenates were analysed by zymography. MMP-9 was not detectable in nonwounded skin, but an increase in MMP-9 protein was observed postinjury (Figure 6a ). MMP-9 protein levels in wt wounds were highest at day 1 postwounding after which time expression began to subside (Figure 6a and b) . MMP-9 was differentially regulated in wt and TNF-a À/À wounds (Figure 6a and b). MMP-9 expression was induced to a lesser extent in TNF-a À/À wounds at day 1 postinjury (Figure 6b , 2.2-fold compared with wt) but by days 3 and 6 MMP-9 expression was higher in TNF-a À/À wounds compared with wt (Figure 6b, 1 .4-and two-fold respectively).
Collectively, these data suggest that TNF-a plays an important role during keratinocyte migration in vitro and re-epithelialization following wounding in vivo. TNF-a may regulate keratinocyte migration in an MMP-9-dependent manner since blockade of MMP-9 inhibited migration in vitro and the initial delay in reepithelialization observed in TNF-a À/À mice correlated with decreased MMP-9 expression in vivo. Since TNF-a blockade reduced the migratory capacity of keratinocytes in vitro and in vivo, we next investigated the possibility that TNF-a may regulate the level of a cell surface receptor involved in keratinocyte migration. Integrins are a family of transmembrane receptors known to play roles in adhesion and migration (Watt, 2002) . TNF-a has recently been shown to regulate integrin family members on a variety of cell types (Milner and Campbell, 2003; Nakao et al., 2003) so we used a gene expression profiling system to compare the integrin expression pattern in wt and TNF-a À/À keratinocytes in vitro.
Expression of av and b6 integrin subunits is reduced in TNF-a À/À keratinocytes and blockade of avb6 inhibits wt keratinocyte migration in vitro Gene expression profiling revealed that wt keratinocytes expressed mRNA for several integrin subunits and Figure 6 MMP-9 expression is differentially regulated during wound healing in TNF-a À/À mice. wt and TNF-a À/À mice were wounded using a 5-mm punch biopsy and wound samples were collected at the times indicated. Protein was isolated and MMP-9 protein levels in wt and TNF-a À/À (À/À) wound samples were measured by zymography (a). Relative levels of MMP-9 protein in wt ( ) and TNF-a À/À (') (b). Data are representative of at least two independent experiments TNF-a regulation of MMP-9 and integrin avb6 in skin KA Scott et al genetic deletion of TNF-a selectively altered the expression of av and b6 integrin subunits (Figure 7a ). Levels of av and b6 expression were lower in TNF-a À/À compared with wt keratinocytes (Figure 7a , 3.1-and 2.3-fold respectively). b6 protein expression was also significantly reduced in TNF-a À/À compared with wt keratinocytes when measured by Western blotting (Figure 7b , P ¼ 0.0286). A reduced level of b6 protein is indicative of reduced avb6 expression since b6 heterodimerizes exclusively with av (Breuss et al., 1993) . To investigate the putative role of avb6 in primary keratinocyte migration we compared migration of wt keratinocytes in the presence or absence of a avb6 neutralizing antibody. Blockade of avb6 inhibited keratinocyte migration 3.4-fold (Figure 7c , Po0.0001), suggesting that avb6 plays an important role in primary keratinocyte migration.
TNF-a regulates avb6 and MMP-9 expression in keratinocytes in vitro Since loss of TNF-a inhibited MMP-9 and avb6 expression, we investigated whether treatment of keratinocytes with TNF-a would induce expression of avb6 and MMP-9 protein. FACS analysis revealed that expression of avb6 protein increased in TNF-a À/À keratinocytes in a dose-dependent manner following treatment with TNF-a. The mean fluorescence was increased 2.1-, 2.9-and 3.4-fold compared with control in TNF-a À/À keratinocytes after treatment with 0.1, 1 and 10 ng/ml TNF-a respectively (Figure 8a) . Similarly, treatment of TNF-a À/À keratinocytes with TNF-a increased MMP-9 expression in a dose-dependent manner. MMP-9 protein expression was increased 1.4-and three-fold compared with control in TNF-a À/À keratinocytes treated with 1 and 10 ng/ml TNF-a, respectively (Figure 8b, i and ii; P ¼ 0.029). These data suggest that TNF-a upregulates avb6 and MMP-9 expression in a coordinate manner. Treatment of wt keratinocytes with TNF-a also induced expression of avb6 and MMP-9 (data not shown). Induction of avb6 and MMP-9 expression in wt keratinocytes was lower than the level of induction observed in TNF-a À/À keratinocytes. This may be explained by the fact that wt keratinocytes secrete low levels of TNF-a in culture (30 pg/ml), which may reduce the response of these cells to exogenous TNF-a.
TNF-a regulates MMP-9 expression via an avb6-dependent pathway in keratinocytes in vitro avb6 has previously been shown to regulate MMP-9 protein expression in normal keratinocytes and SCC in vitro (Thomas et al., 2001a, b) . Thus, we next investigated whether avb6 was required for TNF-a-mediated regulation of MMP-9. TNF-a À/À keratinocytes were used for this work since wt keratinocytes displayed a reduced response to exogenous TNF-a in culture (described above). As observed in Figure 8 , treatment of TNF-a À/À keratinocytes with 10 ng/ml TNF-a induced MMP-9 expression (Figure 9a, control) . Addition of an avb6 neutralizing antibody significantly reduced MMP-9 expression in wt (data not shown) and TNF-a À/À keratinocytes (Figure 9a and b, 3.2-fold; P ¼ 0.0022), suggesting that TNF-a regulates MMP-9 via an avb6-dependent pathway in keratinocytes in vitro.
b6 integrin mRNA is differentially regulated in TNF-a À/À mice during tumour promotion
To investigate the possibility that TNF-a regulates avb6 expression during tumour promotion in vivo, levels of b6 mRNA were measured in TPA treated wt and TNF-a À/À epidermis by real time RT-PCR ( Figure 10 ). TPA induced b6 mRNA in wt mice as early as 2 h (12.8-fold) and expression was maximal at 8 h following one application of TPA (39-fold higher than control). However, TPA-induced b6 expression was reduced in TNF-a À/À mice at all keratinocytes and blockade of avb6 inhibits keratinocyte migration in vitro. mRNA was isolated from wt and TNF-a À/À keratinocytes and the integrin gene expression profile was analysed using a GEArrayt original series kit. av (elipse) and b6 (rectangle) integrin mRNA levels were reduced in TNF-a À/À compared with wt keratinocytes (a). Protein was isolated from wt and TNF-a À/À keratinocytes and b6 protein expression was measured by Western blotting. Expression of b6 protein was reduced in TNF-a À/À compared with wt keratinocytes (b, asterisk denotes P ¼ 0.0286). Migration of wt keratinocytes in vitro was measured in the presence or absence of 10 mg/ml anti-mouse avb6 antibody in the upper chamber. Results are expressed as number of cells per field ( Â 200 magnification). Error bars represent mean7s.e., (n ¼ 27). Blockade of avb6 function inhibits migration of wt keratinocytes (c, asterisk denotes Po0.0001). Data are representative of at least two independent experiments timepoints examined when compared with wt ( Figure 10 ). These data suggest the involvement of TNF-a in the regulation of TPA-stimulated b6 expression in vivo.
Discussion
The mouse skin carcinogenesis model is a multistage process involving initiation, promotion and progression. keratinocytes treated with TNF-a (b). MMP-9 induction was measured by zymography (i) and relative levels of MMP-9 were determined (ii). MMP-9 expression was significantly increased by TNF-a treatment compared with control (ii, asterisk denotes P ¼ 0.0286). Data are representative of at least two independent experiments Genes that play an important role in skin carcinogenesis, such as TNF-a, have been recently identified using genetically manipulated mice. The precise mechanism of tumour formation in this model has yet to be elucidated, although clonal expansion of initiated follicular stem cells has been reported to involve migration out of the hair follicle and into the surrounding interfollicular epidermis (Binder et al., 1997) . MMP-9 is upregulated in a variety of cancers and several studies have indicated that recruited inflammatory cells secrete MMP-9 in the tumour microenvironment (Bergers et al., 2000; Coussens et al., 2000) . Other studies show that tumour cells use this stromal supply of MMP-9 to invade and metastasize to other tissues (Naylor et al., 1994; Nielsen et al., 1996) . Very few studies have investigated the potential role of MMP-9 in tumour formation in vivo.
Work described here identifies MMP-9 as a TNF-a regulated gene during the early stages of tumour promotion and suggests a possible role for MMP-9 in keratinocyte migration during tumour development. Using in vivo and in vitro keratinocyte migration models we provide some evidence for our hypothesis that TNFa may stimulate keratinocyte migration out of the hair follicle and into the surrounding interfollicular epidermis during tumour promotion. Our data suggest that keratinocyte migration is regulated by TNF-a and occurs via an MMP-9-and avb6 integrin-dependent pathway. This may be a general mechanism that facilitates early neoplastic cell movement and proliferation leading to tumour formation. To our knowledge, we have shown, for the first time, that during the initial stages of skin tumour development MMP-9 is specifically upregulated in an area where initiated cells are believed to reside (Morris et al., 2000b) and that MMP-9 expression is exclusively localized to the epidermis during all stages of skin tumour promotion.
Our data suggest that TNF-a may be the major regulator of the MMP-9 induction initially observed following an insult to the skin. Indeed, loss of TNF-a inhibited MMP-9 expression during the early stages of both skin carcinogenesis and wound healing. The wound healing data presented in this study clearly show that MMP-9 expression is elevated in TNF-a deficient wounds after re-epithelialization is already complete in normal skin. This may explain, in part, why loss of TNF-a resulted in only a temporary delay in reepithelialization. Similarly, by the end of tumour promotion, epithelial mRNA MMP-9 expression appeared to be equally strong in both normal and TNF-a deficient epidermis (data not shown). These observations suggest that factors controlling MMP-9 expression change during the course of tumour promotion and wound healing. Indeed, one report suggests that TGFb1 may be involved in control of MMP-9 during later stages of skin carcinogenesis resulting in tumour invasion and distant metastasis (Weeks et al., 2001) .
In our study we show that TNF-a plays a major role in keratinocyte migration in vivo and in vitro. Use of a wound healing model revealed that TNF-a regulates keratinocyte migration across the wound bed. Investigation of TNF-a function during wound healing is relevant to the skin carcinogenesis model since it has been suggested that TPA activity may mimic the natural Figure 10 b6 mRNA expression is differentially regulated in TNFa À/À epidermis during tumour promotion. b6 mRNA expression was measured by real time RT-PCR in wt and TNF-a À/À epidermis at the times indicated after one application of TPA. Induction of b6 mRNA by TPA in wt (') and TNF-a À/À (&) epidermis was compared with acetone control at each time point. Error bars represent mean7s.e., (n ¼ 3). Data are representative of at least two independent experiments Figure 9 TNF-a regulates MMP-9 expression via an avb6-dependent pathway in keratinocytes in vitro. TNF-a À/À keratinocytes were treated with 10 ng/ml TNF-a710 mg/ml of an anti-avb6 neutralizing antibody. Levels of MMP-9 protein in cell culture supernatant were measured by zymography (a). TNF-a-induced MMP-9 protein expression was significantly decreased by neutralization of avb6 compared with control (b; asterisk denotes P ¼ 0.0022). Data are representative of at least two independent experiments response of the skin to injury (Murphy et al., 2003) . Little is known regarding the precise role of TNF-a during wound healing and conflicting evidence exists in the literature (Buck et al., 1996; Hubner et al., 1996; Lee et al., 2000; Mori et al., 2002) . TNF-a has been previously detected in the hyperproliferative epithelium at the wound edge and a reduced induction of cytokines, such as TNF-a, has been associated with impaired wound healing (Hubner et al., 1996) . However, mice deficient in TNFR1 displayed accelerated wound healing (Mori et al., 2002) . To our knowledge, this is the first time that TNF-a has been conclusively shown to delay re-epithelialization. TNF-a can bind to two receptors (TNFR1 and TNFR2; MacEwan, 2002) and we have previously detected both TNF-a receptor subtypes in mouse epidermis (Arnott et al., 2004) . The specific roles of TNFR1 and TNFR2 in epidermis during normal and pathological processes have yet to be defined and so an yet unidentified role of TNFR2 may explain the accelerated re-epithelialization observed in TNFR1 deficient mice (Mori et al., 2002) .
Our data suggest that TNF-a regulates keratinocyte migration in vitro and in vivo via an avb6-and MMP-9-dependent pathway. The role of avb6 in keratinocyte migration in normal and pathological processes is well established. avb6 is known to be induced in keratinocytes during wound healing in vivo and during culture in vitro (Watt, 2002) . Upregulation of avb6 also promotes invasion of SCC cells in vitro and de novo expression of avb6 in SCC in vivo is thought to be involved in tumour progression (Thomas et al., 2001a (Thomas et al., , 2002 . However, little is known regarding factors that control avb6 expression. To date, TGF-b is the only cytokine that has been shown to regulate avb6 (Breuss et al., 1995) . We present here the novel observation that TNF-a regulates avb6 expression on keratinocytes in vitro and during tumour promotion in vivo. Since we have shown previously that TNF-a mediates tumour promotion via an AP-1-dependent pathway (Arnott et al., 2002 (Arnott et al., , 2004 , in vivo data described here suggest that avb6 may be an AP-1 regulated gene. A role for avb6 has not been previously described in events leading to tumour development, but in agreement with several reports (Thomas et al., 2001a, b) avb6 appeared to play a role in regulation of keratinocyte MMP-9 expression. avb6 regulation of TNF-a-induced MMP-9 may be vital for initiated cell migration and clonal expansion during tumour promotion.
In summary, data presented here show for the first time an important role for TNF-a in keratinocyte migration during wound healing and tumour promotion. TNF-a appears to stimulate keratinocyte migration via expression of avb6 and MMP-9. Since initiated keratinocytes are thought to repopulate other areas of the epidermis when they clonally expand (Binder et al., 1997) , a failure of initiated stem cells to migrate into the interfollicular epidermis and surrounding hair follicles during tumour promotion may have a profound effect on tumour formation. Thus, TNF-a may elicit its tumour promoting activity by stimulating tumour cell movement during the early stages of skin carcinogenesis.
Induction of TNF-a coupled to an increase in MMP-9 and avb6 expression may be a general mechanism for epithelial cell migration in inflammation, wound healing and malignancy. Hence, deregulated expression of TNFa by epithelial cells may mediate early neoplastic cell movement and proliferation leading to enhanced tumour development.
Materials and methods

Mice
Mice homozygous for the mutant TNF-a knockout allele (TNF-a À/À ) and wild-type (wt) mice were maintained on a BALB/c background. wt and TNF-a À/À female mice were age matched to within 3 days. A 1-2 cm 2 area of dorsal skin was shaved with electric clippers when mice were between 6 and 6.5 weeks old.
Skin carcinogenesis
The shaved dorsal skin of wt and TNF-a À/À mice was initiated with a single topical application of 9,10-dimethyl-1,2-benzanthracene (DMBA; 25 mg in 100 ml acetone; Sigma, Poole, UK) at 7 weeks of age. 1 week later, TPA (4 mg in 100 ml acetone; Sigma) was applied to the shaved area. Mice received two applications of TPA per week for up to 15 weeks. Control mice were treated with acetone alone. Samples were harvested at the times indicated. Mice were killed, treated skin was removed and spread onto card. For histological analysis and ISH, treated skin was fixed in formal saline and embedded in paraffin wax. For protein expression analysis treated skin was snap frozen in liquid nitrogen.
In vivo wounding
The shaved dorsal skin of wt and TNF-a À/À female mice was wounded using a 5-mm punch biopsy under general anaesthesia. Wounds were left uncovered and wound diameter was measured daily using calipers. Mice were killed at the times indicated, wounded skin was removed and spread onto card. For histological analysis, wounded skin was fixed in formal saline and embedded in paraffin wax. Wounds were bisected, sections were cut and stained with haematoxylin and eosin (H&E). For protein and mRNA expression analysis, wounded skin was snap frozen in liquid nitrogen.
BrdU incorporation
BrdU labelling was performed at the times indicated following in vivo wounding. Mice were injected with 50 mg/kg BrdU (Sigma) 1 h before the end of the experiment. Wounded skin was fixed in formal saline and embedded in paraffin wax. Wounds were bisected, sections were cut and stained with an anti-BrdU monoclonal antibody (Abcam, Cambridge, UK) using standard procedures.
In situ hybridization
Antisense and sense riboprobes with a-35 S-labelled UTP were generated for mouse MMP-9. MMP-9 cDNA was a kind gift from Professor Karl Tryggvason (University of Oulu, Finland). Antisense b-actin was used as a positive control in all experiments. ISH for MMP-9 mRNA was carried out on paraffin sections prepared from wt and TNF-a À/À TPA treated skin, according to the method previously described (Steel et al., 1998) .
Fractionation of follicular and interfollicular epidermis
Mice were killed and dorsally shaved TPA treated skin was removed. For RNA extraction, skin was agitated in warm water (601C) for 5 s, spread onto card and interfollicular epidermis was scraped from the dermis using a spatula. For protein extraction, interfollicular epidermis was scraped from the dermis of frozen skin samples using a surgical scalpel. Abraded skin (dermis from which the interfollicular epidermis has been scraped) was defined as 'follicular epidermis' for the determination of MMP-9 expression levels; any MMP-9 mRNA detected in abraded skin would be from cells located in follicular epidermis since MMP-9 mRNA was exclusively expressed in epidermis following TPA treatment as measured by ISH.
Isolation of mRNA and analysis by real time RT-PCR RNA was extracted from interfollicular epidermis and abraded skin using solution D as described previously (Chomczynski and Sacchi, 1987) . For wound samples, an 8 mm punch biopsy was used to harvest the wound area and margins from frozen wound skin and samples were homogenized in solution D. Interfollicular epidermis, abraded skin or wound tissue from three mice was pooled for each sample. Reverse transcription of RNA and real time RT-PCR was performed as described previously (Arnott et al., 2004) . Real time RT-PCR analysis was performed using primers and probe (FAM) that were either premade (b6 integrin) or designed using Primer Express 1.5a (MMP-9; Forward 5 0 -CCAAGGGTACAGCCTGT TCCT-3 0 ; Reverse 5 0 -GCACGCTGGAATGATCTAAGC-3 0 and probe 5 0 -CGCACGAGTTCGGCCATGCAC-3 0 ). Multiplex real time RT-PCR analysis was performed using the target primers and probe (FAM) and 18 s rRNA primers and probe (VIC) with the ABI PRISM 7700 Sequence Detection System instrument and software (PE Applied Biosystems, Warrington, UK). MMP-9 and b6 integrin were normalized (DCt) to 18 s rRNA by subtracting the cycle threshold (Ct) value of 18 s rRNA from the Ct value of the gene of interest. 
Preparation of whole-cell protein homogenates
Protein was extracted from interfollicular epidermis and abraded skin samples as described previously (Arnott et al., 2004) . For wound samples, an 8 mm punch biopsy was used to harvest the wound area and margins from frozen wound skin and samples were homogenized as described previously (Arnott et al., 2004) . Interfollicular epidermis, abraded skin or wound tissue from three mice was pooled for each sample. Total protein concentration was determined using the BCA protein assay kit, according to the manufacturer's instructions.
Forward zymography
MMP-9 protein was measured by zymography as described previously (Leber and Balkwill, 1997). To visualize the proform of MMP-9, equal amounts of skin carcinogenesis samples (10 mg total protein) or wound samples (2.5 mg total protein) were loaded into each well with nonreducing sample buffer. Protein identity was confirmed using a proMMP-9 standard (R&D Systems). Where indicated proMMP-9 band intensity was quantified using NIH Image 1.61 image analysis program.
Reverse zymography
To measure TIMP activity, equal amounts of skin carcinogenesis samples (12 mg total protein) were analysed using a reverse zymography kit, according to the manufacturer's instructions. The reverse zymography kit was a kind gift from Professor Dylan Edwards (University of East Anglia, UK). TIMP-3 band intensity was quantified using NIH Image 1.61 image analysis program.
ELISA
Levels of TNF-a protein in wound samples were measured using a murine TNF-a ELISA assay (R&D systems, Oxon, UK). Samples were assayed at 3 mg/ml total protein and TNFa protein was measured according to the manufacturer's instructions.
Isolation and culture of primary keratinocytes
wt and TNF-a À/À newborn keratinocytes were isolated from 2-4-day-old mice as described previously (Arnott et al., 2004) . For experiments, keratinocytes were trypsinized and plated at 7.5 Â 10 5 cells per well in six-well plates. Where indicated keratinocytes were treated with increasing concentrations of recombinant murine TNF-a (R&D systems) as described in Arnott et al. (2004) . Keratinocytes were also treated with 10 ng/ml TNF-a and 10 mg/ml anti-mouse avb6 antibody (Clone 10D5; Chemicon International, London, UK). Cell culture supernatant was collected 24 h after TNF-a treatment and MMP-9 was measured in cell-free supernatant by zymography.
Migration of primary keratinocytes
Migration assays were performed using migration chambers (8 mm pore inserts) coated with matrigel (Becton Dickinson), according to the manufacturer's instructions. Keratinocytes were trypsinized and seeded at 2.5 Â 10 5 cells per upper chamber in FAD containing 1% (w/v) BSA. Keratinocytes were allowed to migrate to FAD media containing 10% FBS in the lower chamber for 20 h. Where indicated the following additions were present in the upper chamber; 1 mg/ml of an anti-mouse TNF-a antibody (Cat No. AF-410-NA, R&D Systems), 5 ng/ml murine TIMP-3 protein (R&D Systems), 1 mg/ml of an anti-mouse MMP-9 antibody (Clone GE-213; Chemicon International), 15 nM of an MMP inhibitor (Calbiochem, Nottingham, UK) and 10 mg/ml anti-mouse avb6 antibody (Clone 10D5, Chemicon International). Where appropriate a control isotype matched antibody (R&D systems) was used to test for nonspecific inhibition of migration. Invasion chambers were processed according to the manufacturer's instructions. Keratinocytes that had invaded were observed at Â 200 on a light microscope. Invasions were performed in quadruplicate and at least 27 fields of view were counted per condition.
Integrin gene expression profiling
mRNA from wt and TNF-a À/À keratinocytes was isolated using solution D as described previously (Chomczynski and Sacchi, 1987) . In total, 5 mg of mRNA was used to investigate the integrin expression pattern using a GEArrayt Original series kit, according to the manufacturer's instructions (Superarray, Bethesda, USA). Expression was quantified using GEArray analyzer v1.3 software (Superarray).
Western blotting
Whole-cell extracts of wt and TNF-a À/À keratinocytes were prepared for analysis of b6 protein by Western blotting using an anti-b6 antibody (Clone C-19, Autogen Bioclear, Wiltshire, UK). Briefly, adherent cells were scraped into ice-cold cell lysis buffer (1% (v/v) Triton-X-100, 0.5% (w/v) sodium deoxycholate and 0.1% (w/v) SDS in PBS). Samples were homogenized using a 25 g needle, then centrifuged at 15000 Â g for 10 min. The supernatant was collected and total protein concentration was determined using the BCA protein assay kit (Sigma), according to the manufacturer's instructions. Normalized protein samples were subjected to Western blotting as described previously (Arnott et al., 2004) .
Flow cytometry
wt and TNF-a À/À keratinocytes were trypsinized and resuspended in FACS buffer (PBS containing 1 mM MgCl 2 and 0.1% BSA). Keratinocytes were blocked for 15 min at 41C with CD16/32 Fc block (BD Pharmingen, Oxford, UK) and subsequently incubated on ice with 1 mg anti-avb6antibody (Clone 10D5, Chemicon International) or isotype control antibody IgG2a-FITC (BD Pharmingen) for 30 min. Keratinocytes were washed three times in FACS buffer and incubated with anti-mouse Alexa Fluor 488 (1 : 200 dilution; Cambridge Bioscience, Cambridge, UK) on ice for 30 min. Keratinocytes were washed three times, resuspended in FACS buffer and subsequently analysed on a FACScan s flow cytometer using Cellquest software (Beckton Dickinson).
Statistics
Where indicated data were tested for statistical significance by the nonparametric Mann-Whitney U test using InStat Version 2.01 software.
